vs
Amplitude, Inc.（AMPL）与IRONWOOD PHARMACEUTICALS INC（IRWD）财务数据对比。点击上方公司名可切换其他公司
Amplitude, Inc.的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.9倍（$91.4M vs $47.7M），IRONWOOD PHARMACEUTICALS INC净利率更高（-4.8% vs -19.3%，领先14.5%），Amplitude, Inc.同比增速更快（17.0% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $12.7M），过去两年Amplitude, Inc.的营收复合增速更高（12.2% vs -20.2%）
Amplitude是一家美国企业，专注于研发数字分析软件，能够帮助企业梳理用户行为数据、优化产品决策与数字化运营体验。该公司于2021年9月28日在纳斯达克交易所挂牌上市，股票代码为AMPL。
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
AMPL vs IRWD — 直观对比
营收规模更大
AMPL
是对方的1.9倍
$47.7M
营收增速更快
AMPL
高出64.3%
-47.3%
净利率更高
IRWD
高出14.5%
-19.3%
自由现金流更多
IRWD
多$61.9M
$12.7M
两年增速更快
AMPL
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $91.4M | $47.7M |
| 净利润 | $-17.7M | $-2.3M |
| 毛利率 | 74.6% | — |
| 营业利润率 | -18.3% | 14.3% |
| 净利率 | -19.3% | -4.8% |
| 营收同比 | 17.0% | -47.3% |
| 净利润同比 | 45.8% | -200.9% |
| 每股收益（稀释后） | $-0.13 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPLIRWD
| Q4 25 | $91.4M | $47.7M | ||
| Q3 25 | $88.6M | $122.1M | ||
| Q2 25 | $83.3M | $85.2M | ||
| Q1 25 | $80.0M | $41.1M | ||
| Q4 24 | $78.1M | $90.5M | ||
| Q3 24 | $75.2M | $91.6M | ||
| Q2 24 | $73.3M | $94.4M | ||
| Q1 24 | $72.6M | $74.9M |
净利润AMPLIRWD
| Q4 25 | $-17.7M | $-2.3M | ||
| Q3 25 | $-24.0M | $40.1M | ||
| Q2 25 | $-24.7M | $23.6M | ||
| Q1 25 | $-22.2M | $-37.4M | ||
| Q4 24 | $-32.6M | $2.3M | ||
| Q3 24 | $-16.9M | $3.6M | ||
| Q2 24 | $-23.4M | $-860.0K | ||
| Q1 24 | $-21.5M | $-4.2M |
毛利率AMPLIRWD
| Q4 25 | 74.6% | — | ||
| Q3 25 | 73.9% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 74.7% | — | ||
| Q4 24 | 74.7% | — | ||
| Q3 24 | 75.1% | — | ||
| Q2 24 | 73.4% | — | ||
| Q1 24 | 74.0% | — |
营业利润率AMPLIRWD
| Q4 25 | -18.3% | 14.3% | ||
| Q3 25 | -26.0% | 61.8% | ||
| Q2 25 | -29.0% | 53.2% | ||
| Q1 25 | -26.8% | -70.7% | ||
| Q4 24 | -41.2% | 34.8% | ||
| Q3 24 | -21.4% | 28.0% | ||
| Q2 24 | -31.7% | 26.5% | ||
| Q1 24 | -29.0% | 14.7% |
净利率AMPLIRWD
| Q4 25 | -19.3% | -4.8% | ||
| Q3 25 | -27.1% | 32.8% | ||
| Q2 25 | -29.6% | 27.7% | ||
| Q1 25 | -27.8% | -90.9% | ||
| Q4 24 | -41.7% | 2.5% | ||
| Q3 24 | -22.4% | 4.0% | ||
| Q2 24 | -31.9% | -0.9% | ||
| Q1 24 | -29.5% | -5.6% |
每股收益（稀释后）AMPLIRWD
| Q4 25 | $-0.13 | $0.01 | ||
| Q3 25 | $-0.18 | $0.23 | ||
| Q2 25 | $-0.19 | $0.14 | ||
| Q1 25 | $-0.17 | $-0.23 | ||
| Q4 24 | $-0.25 | $0.03 | ||
| Q3 24 | $-0.14 | $0.02 | ||
| Q2 24 | $-0.19 | $-0.01 | ||
| Q1 24 | $-0.18 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $192.0M | $215.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.3M | $-261.8M |
| 总资产 | $420.7M | $396.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMPLIRWD
| Q4 25 | $192.0M | $215.5M | ||
| Q3 25 | $189.2M | $140.4M | ||
| Q2 25 | $208.1M | $92.9M | ||
| Q1 25 | $209.0M | $108.5M | ||
| Q4 24 | $241.1M | $88.6M | ||
| Q3 24 | $319.9M | $88.2M | ||
| Q2 24 | $318.3M | $105.5M | ||
| Q1 24 | $316.1M | $121.5M |
总债务AMPLIRWD
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
股东权益AMPLIRWD
| Q4 25 | $245.3M | $-261.8M | ||
| Q3 25 | $262.2M | $-264.2M | ||
| Q2 25 | $279.5M | $-308.2M | ||
| Q1 25 | $289.5M | $-334.1M | ||
| Q4 24 | $296.6M | $-301.3M | ||
| Q3 24 | $290.0M | $-311.3M | ||
| Q2 24 | $287.3M | $-321.7M | ||
| Q1 24 | $289.2M | $-330.5M |
总资产AMPLIRWD
| Q4 25 | $420.7M | $396.9M | ||
| Q3 25 | $438.1M | $396.1M | ||
| Q2 25 | $456.6M | $342.9M | ||
| Q1 25 | $445.8M | $327.2M | ||
| Q4 24 | $445.9M | $350.9M | ||
| Q3 24 | $445.6M | $389.5M | ||
| Q2 24 | $445.4M | $395.6M | ||
| Q1 24 | $437.9M | $438.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.8M | $74.6M |
| 自由现金流经营现金流 - 资本支出 | $12.7M | $74.6M |
| 自由现金流率自由现金流/营收 | 13.8% | 156.3% |
| 资本支出强度资本支出/营收 | 0.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $28.2M | $127.0M |
8季度趋势，按日历期对齐
经营现金流AMPLIRWD
| Q4 25 | $12.8M | $74.6M | ||
| Q3 25 | $5.0M | $47.6M | ||
| Q2 25 | $20.1M | $-15.1M | ||
| Q1 25 | $-8.0M | $20.0M | ||
| Q4 24 | $3.2M | $15.2M | ||
| Q3 24 | $6.2M | $9.9M | ||
| Q2 24 | $9.2M | $33.5M | ||
| Q1 24 | $-48.0K | $45.0M |
自由现金流AMPLIRWD
| Q4 25 | $12.7M | $74.6M | ||
| Q3 25 | $4.5M | $47.6M | ||
| Q2 25 | $19.5M | $-15.1M | ||
| Q1 25 | $-8.5M | $19.9M | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $6.2M | $9.9M | ||
| Q2 24 | $8.6M | $33.4M | ||
| Q1 24 | $-405.0K | $44.9M |
自由现金流率AMPLIRWD
| Q4 25 | 13.8% | 156.3% | ||
| Q3 25 | 5.1% | 39.0% | ||
| Q2 25 | 23.4% | -17.7% | ||
| Q1 25 | -10.6% | 48.4% | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 8.2% | 10.8% | ||
| Q2 24 | 11.8% | 35.4% | ||
| Q1 24 | -0.6% | 60.0% |
资本支出强度AMPLIRWD
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.5% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 1.0% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.8% | 0.1% | ||
| Q1 24 | 0.5% | 0.1% |
现金转化率AMPLIRWD
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPL
| US | $55.8M | 61% |
| International | $35.7M | 39% |
IRWD
暂无分部数据
